Should I Buy Harmony Biosciences Holdings Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. HRMY has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
HRMY stock price ended at $29.61 on Friday, after rising0.61%
The Harmony Biosciences Holdings Inc stock price increased by 0.61% on the last trading day (Friday Apr 2025), rising from 29.43 to 29.61. Throughout the last trading session, the stock experienced a fluctuation of 2.65% , ranging from a day low of $28.865 to a day high of 29.63. The price has declined in 3 of the last 10 days, resulting in a total change of 2.14% during this period. On the last day, trading volume decrease by -91.38K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 307.94K shares were traded, amounting to approximately 9.06M.
HRMY Technical Signals
HRMY(Harmony Biosciences Holdings Inc Corp) has 1 buy signal and 4 sell signals now. The current trend is downtrend starting from 2025-03-24. The total price change during this trend is -13.52%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of HRMY over the last 5 trading days is 15.95M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
HRMY Moving Average Analysis
Harmony Biosciences Holdings Inc's overall moving average trend leans more bearish as of Monday, April 28, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $30.34, and $31.27. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $27.33, and $26.4. A break-down below any of these levels will issue sell signals.
HRMY Short Selling Analysis
The short sale ratio of Harmony Biosciences Holdings Inc(HRMY) as of 25 Apr 2025 is 14.98%, dropping from last trading day. With decreasing price from 29.43 to 29.61. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
4
Buy
1
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 > 0
0.62
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 < 0
-2.44
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-1.11
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
96.87
Bearish
Williams %R (14 days)
WILLR_14 > -20
-10.97
Bearish
HRMY Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Harmony Biosciences Holdings Inc(HRMY), our algorithm predicts HRMY's 1-month price at $67.50, with an 127.97%upwardshift. Using a similarity score up to 98.66%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Harmony Biosciences Holdings Inc (HRMY.O) stock, as of Sunday, April 27, 2025 , forecasts a 127.97% change over the next month, based on its high correlation with VVOS.O stock patterns. The similarity between their price movements over the analyzed periods is 98.66%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
HRMY
VVOS
Up: 127.97%Similarity: 98.66%
Name
Similarity
Up/Down
No Data
HRMY Seasonality Analysis
Based on HRMY's historical stock price data across all years, the probability of a positive return in April is0.00%, suggesting it maynotbe an ideal month to invest in HRMY. In contrast,offers the highest probability of positive returns at20.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Harmony Biosciences Holdings Inc (HRMY.O) stock in November has the highest probability of a positive return (80.00%), while April has the lowest probability (0.00%).
Performance Seasonality
The chart shows Harmony Biosciences Holdings Inc. (HRMY)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Harmony Biosciences Holdings Inc (HRMY.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. HRMY has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Harmony Biosciences Holdings Inc (HRMY.O) stock in a year?
The radar chart shows that buying Harmony Biosciences Holdings Inc (HRMY.O) stock in November has the highest probability of a positive return (80.00%), while April has the lowest probability (0.00%).
How has Harmony Biosciences Holdings Inc. (HRMY)'s stock price performed over the past three years?
HRMY's stock price fell by -39.01% in 2023,increased by 11.76% in 2024, and went down by 14.99% in 2025.
Which bull technical signals does HRMY have?
Bullish technical signals of HRMY include: MOM_10 > 0.
Is HRMY a buy based on overall technical signals summary?
HRMY has 1 buy signals and 4 sell signals now. Overall the technical rating for HRMY is Sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of HRMY.
What is the trend of Harmony Biosciences Holdings Inc (HRMY)'s moving average?
Harmony Biosciences Holdings Inc's overall moving average trend leans more bearish as of April 28 2025, with 3 negative signals and 1 positive signal.
What is price prediction for HRMY stock next month?
The price prediction chart for Harmony Biosciences Holdings Inc (HRMY.O) stock, as of April 27 2025, forecasts a 127.97% change over the next month, based on its high correlation with VVOS stock patterns. The similarity between their price movements over the analyzed periods is 98.66%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for HRMY Stock?
HRMY stock is predicted to reach **$44.00** by the end of 2025. This forecast is supported by strong analyst sentiment, with Mizuho Securities maintaining a Buy rating and a $44.00 price target, while the average analyst consensus suggests a Strong Buy with a $52.50 average price target. The stock's current price of $29.18 reflects undervaluation, with improving financial performance and positive revenue growth.
What is price prediction 2030 for HRMY Stock?
The price prediction for HRMY stock in 2030 is **$60**. This forecast is based on the company's strong revenue growth trajectory, with revenues increasing from $159.74 million in 2020 to a projected $714.73 million in 2024, demonstrating a compound annual growth rate (CAGR) of approximately 35%. Additionally, the average analyst price target of **$52.50** suggests significant upside potential, with some analysts forecasting targets as high as **$75**. The company's lead asset, Wakix, is progressing toward blockbuster status, and the potential success of its pipeline, including ZYN-002, further supports long-term growth prospects.